Healthcare - Biotechnology - NASDAQ - DE
$ 99.72
-3.71 %
$ 25.7 B
Market Cap
-51.94
P/E
BALANCE SHEET
23 B
ASSETS
2.76 B
LIABILITIES
20.2 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
BioNTech SE
| Current Assets | 19.5 B |
| Cash & Short-Term Investments | 16.5 B |
| Receivables | 2.34 B |
| Other Current Assets | 639 M |
| Non-Current Assets | 3.48 B |
| Long-Term Investments | 1.18 B |
| PP&E | 972 M |
| Other Non-Current Assets | 1.33 B |
| Current Liabilities | 2.07 B |
| Accounts Payable | 354 M |
| Short-Term Debt | 56.2 M |
| Other Current Liabilities | 1.66 B |
| Non-Current Liabilities | 690 M |
| Long-Term Debt | 380 M |
| Other Non-Current Liabilities | 310 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 11 663.7 | 13 875.1 | 1 692.7 | 1 210.2 | 519.1 | 411.5 | 172.1 | 303.7 |
| Short Term Investments | 4 885.3 | 189.4 | 381.6 | 137.2 | 1.7 | 0.3 | 0.2 | 1.5 |
| Receivables | 2 339.7 | 7 145.6 | 12 381.7 | 0 | 0 | 18.9 | 4.6 | 6.0 |
| Inventory | 357.7 | 439.6 | 502.5 | 64.1 | 11.7 | 5.8 | 3.9 | 3.3 |
| Other Current Assets | 280.9 | 272.3 | 113.8 | 392.6 | 29.3 | 12.4 | 8.8 | 3.7 |
| Total Current Assets | 19 527.3 | 21 922.0 | 15 072.3 | 1 666.9 | 560.2 | 449.0 | 189.6 | 318.1 |
| PP&E | 971.6 | 821.1 | 520.4 | 326.0 | 148.1 | 116.0 | 101.5 | 60.5 |
| Intangible Assets | 781.7 | 158.5 | 144.6 | 109.8 | 86.5 | 87.5 | 83.0 | 10.7 |
| Goodwill | 362.5 | 61.2 | 57.8 | 53.7 | 3.0 | 0.5 | 0.5 | 0.5 |
| Long Term Investments | 1 176.1 | 80.2 | 21.3 | 0 | 0 | 18 K | 19 K | 66 K |
| Other Long Term Assets | 187.1 | 6.5 | 0.8 | 1.0 | 2 K | 1 K | 2 K | 76 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 23 006.3 | 23 279.1 | 15 830.8 | 2 318.6 | 797.6 | 653.0 | 374.7 | 390.0 |
| LIABILITIES | ||||||||
| Accounts Payable | 354.0 | 204.1 | 160.0 | 102.3 | 20.5 | 41.7 | 52.5 | 6.2 |
| Short Term Debt | 56.2 | 36.0 | 129.9 | 15.2 | 1.8 | 0 | 0 | 0 |
| Other Current Liabilities | 1 134.8 | 2 114.6 | 1 622.8 | 487.6 | 115.7 | 84.1 | 106.0 | 17.0 |
| Total Current Liabilities | 2 070.5 | 2 950.6 | 3 481.6 | 606.0 | 138.1 | 126.1 | 158.5 | 56.6 |
| Long Term Debt | 379.6 | 2.1 | 325.3 | 309.1 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 6.2 | 66.7 | 0.3 | (166.0) | (205.6) | (214.0) | 0 |
| Other Liabilities | 310.3 | 264.6 | 63.5 | 31.7 | 166.0 | 259.9 | 264.4 | 28.1 |
| Total Liabilities | 2 760.4 | 3 223.5 | 3 937.1 | 946.8 | 304.2 | 386.0 | 422.9 | 358.1 |
| EQUITY | ||||||||
| Common Stock | 248.6 | 248.6 | 246.3 | 246.3 | 232.3 | 193.3 | 166.8 | 3.3 |
| Retained Earnings | 19 763.3 | 18 833.0 | 9 882.9 | (409.6) | (424.8) | (245.8) | (197.8) | (112.1) |
| Other Accumulative Comprehensive Income/Loss | 244.8 | 979.3 | 1 768.3 | 25.5 | 691.5 | 318.6 | (18.3) | 139.3 |
| Total Equity | 20 245.9 | 20 055.6 | 11 893.7 | 1 371.8 | 493.5 | 267.0 | (48.2) | 31.9 |
| Total Liabilities and Equity | 23 006.3 | 23 279.1 | 15 830.8 | 2 318.6 | 797.6 | 653.0 | 374.7 | 390.0 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 242.9 | 243.3 | 244.0 | 235.4 | 211.5 | 226.9 | 226.9 |